Herbal Drugs Analysis
Product Description
Brightlabs
-
Country/Region:Netherlands
-
On CPHI since:2021
-
Certificates:2
-
Employees:25 - 49
Company types
Categories
Specifications
Brightlabs
-
Country/Region:Netherlands
-
On CPHI since:2021
-
Certificates:2
-
Employees:25 - 49
Company types
More Products from Brightlabs (3)
-
Product Elemental Impurities
Brightlabs has in-house validated methods for the analysis of elemental impurities in accordance to ICH-Q3D. Brightlabs has a unique approach for ICHQ3D, which guarantees quick turnaround times at reduced cost -
Product Method Development
We are specialist in the method development of analytical methods for analysis of API, Final Drug Products or low level impurities. Usually followed by full validation in accordance to ICH guidelines. -
Product Nitrosamine Analysis
In response to nitrosamines present in pharmaceutical products, the European Medical Agency (EMA) and the US Food and Drug Administration (US FDA) have published requirements and limits related to nitrosamine contaminants. Therefore Brightlabs has developed and validated multiple methods to determine low l...
Brightlabs resources (4)
-
Brochure NDSRI analysis
Brightlabs has developed and validated multiple methods (GC-MS/MS & LC-MS/MS) to determine low level concentrations of Nitrosamines and NDSRIs in Drug Products


